Fondazione Policlinico Agostino Gemelli IRCCS, Roma
Email verificata su
Citata da
Citata da
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
F Pietrantonio, F Petrelli, A Coinu, M Di Bartolomeo, K Borgonovo, ...
European journal of cancer 51 (5), 587-594, 2015
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
R de Wit, J de Bono, CN Sternberg, K Fizazi, B Tombal, C Wülfing, ...
New England Journal of Medicine 381 (26), 2506-2518, 2019
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
S Antoun, E Lanoy, R Iacovelli, L Albiges‐Sauvin, Y Loriot, ...
Cancer 119 (18), 3377-3384, 2013
Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis
R Iacovelli, F Nolè, E Verri, G Renne, C Paglino, M Santoni, MC Rocca, ...
Targeted oncology 11 (2), 143-148, 2016
Metabolic phenotype of bladder cancer
F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ...
Cancer treatment reviews 45, 46-57, 2016
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
S Bracarda, R Iacovelli, L Boni, M Rizzo, L Derosa, M Rossi, L Galli, ...
Annals of Oncology 26 (10), 2107-2113, 2015
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
R Iacovelli, D Alesini, A Palazzo, P Trenta, M Santoni, L De Marchis, ...
Cancer treatment reviews 40 (2), 271-275, 2014
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
M Santoni, U De Giorgi, R Iacovelli, A Conti, L Burattini, L Rossi, ...
British journal of cancer 109 (7), 1755-1759, 2013
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
P Gazzaniga, A Gradilone, A Petracca, C Nicolazzo, C Raimondi, ...
Journal of cellular and molecular medicine 14 (8), 2073-2077, 2010
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort
R Iacovelli, G Cartenì, CN Sternberg, M Milella, M Santoni, G Di Lorenzo, ...
European journal of cancer 49 (9), 2134-2142, 2013
The cardiovascular toxicity of abiraterone and enzalutamide in prostate cancer
R Iacovelli, C Ciccarese, E Bria, M Romano, E Fantinel, D Bimbatti, ...
Clinical genitourinary cancer 16 (3), e645-e653, 2018
Tumor growth rate provides useful information to evaluate sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: an integrated analysis of the TARGET …
C Ferte, S Koscielny, L Albiges, L Rocher, JC Soria, R Iacovelli, Y Loriot, ...
European urology 65 (4), 713-720, 2014
Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
R Iacovelli, A Palazzo, S Mezi, F Morano, G Naso, E Cortesi
Acta Oncologica 51 (7), 873-879, 2012
Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney
E Risi, R Iacovelli, A Altavilla, D Alesini, A Palazzo, C Mosillo, P Trenta, ...
Urology 82 (2), 382-386, 2013
Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma
R Iacovelli, E Lanoy, L Albiges, B Escudier
BJU International-British Journal of Urology 110 (11), 1747, 2012
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum
A Frega, P Scirpa, R Corosu, M Verrico, ML Scarciglia, MR Primieri, ...
Anticancer research 27 (4C), 2743-2746, 2007
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy
C Ciccarese, F Massari, R Iacovelli, M Fiorentino, R Montironi, ...
Cancer Treatment Reviews 54, 68-73, 2017
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies
R Iacovelli, F Pietrantonio, A Farcomeni, C Maggi, A Palazzo, F Ricchini, ...
PLoS One 9 (9), e108940, 2014
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
F Pietrantonio, C Cremolini, F Petrelli, M Di Bartolomeo, F Loupakis, ...
Critical reviews in oncology/hematology 96 (1), 156-166, 2015
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors
M Santoni, A Conti, S Partelli, C Porta, CN Sternberg, G Procopio, ...
Annals of surgical oncology 22 (6), 2094-2100, 2015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20